Effect of Bailing Capsules Adjuvant Treatment on the Quantification of Urinary MCP-1, mAlb and 24h U-rinary Protein in Pediatric Patients with Henoch-schonlein Purpura Nephritis
- VernacularTitle:百令胶囊辅助治疗对紫癜性肾炎患儿尿 MCP-1、mAlb 及24 h尿蛋白定量的影响
- Author:
Xiuguo LIU
;
Qin SHAO
;
Peng LIU
- Publication Type:Journal Article
- Keywords:
Bailing capsules;
Monocyte chemoattractant protein-1;
Microalbuminuria;
Henoch-schonlein purpura nephritis;
Kidney damage
- From:
China Pharmacist
2016;19(7):1305-1306,1307
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the effect of Bailing capsules adjuvant therapy on urinary monocyte chemoattractant protein-1( MCP-1), microalbuminuria(mAlb) and 24h urinary protein(Up)in the children with henoch-schonlein purpura nephritis(HSPN). Methods:Totally 64 cases of HSPN children were randomly divided into two groups with 32 cases in each .The normal group was given the conventional hormone , dipyridamole and loratadine etc .The Bailing group was orally treated with Bailing capsules additionally .The therapy course was 4 weeks, the changes of MCP-1,mAlb and 24hUp in the groups before and after the treatment were observed .Re-sults:Before the treatment, the levels of MCP-1,mAlb and 24hUp were similar between the groups (P>0.05).After the 4-week treatment, the levels of MCP-1,mAlb and 24hUp were lower than those before the treatment (P<0.05),and the decrease in Bailing group was more significant than that in the normal group (P<0.05).Conclusion:Bailing capsules adjuvant treatment for HSPN can significantly reduce albuminuria and improve renal function .
